Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia

Katie P Truong; Jessica J Zhang; Marwah Shahid; Aditya Goud; Michael Rosove; Jesse Currier; Kamran Shamsa; Rushi V Parikh

doi:10.1016/j.jaccas.2021.06.022

Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia

JACC Case Rep. 2021 Oct 20;3(14):1625-1629. doi: 10.1016/j.jaccas.2021.06.022.

Authors

Katie P Truong¹, Jessica J Zhang¹, Marwah Shahid², Aditya Goud², Michael Rosove³, Jesse Currier⁴, Kamran Shamsa², Rushi V Parikh²

Affiliations

¹ Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
² Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
³ Division of Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
⁴ Division of Cardiology, Department of Veterans Affairs Medical Center, Los Angeles, California, USA.

Abstract

In the present case report, we describe the management of severe coronary artery disease in a patient with Glanzmann thrombasthenia. To the best of our knowledge, there are no established guidelines for revascularization in this setting, and we pose novel discussion points regarding the nuanced care of this patient. (Level of Difficulty: Intermediate.).

Keywords: ADP, adenosine diphosphate; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCTA, coronary computed tomography angiography; DAPT, dual antiplatelet therapy; DES, drug-eluting stent; GT, Glanzmann thrombasthenia; Glanzmann thrombasthenia; LAD, left anterior descending coronary artery; LIMA, left internal mammary artery; PCI, percutaneous coronary intervention; coronary artery disease; dual antiplatelet therapy; percutaneous coronary intervention.

Publication types

Case Reports